The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Complement Targeted Therapeutics Market Research Report 2025
Synopsis
The complement system is a part of the immune system that enhances, or complements, the ability of antibodies to clear small organisms or damaged cells from an organism, promote inflammation and attack the pathogen’s cell membrane. While the complement system is essential to maintaining health, it can also become over-activated, contributing to the development of numerous devastating diseases.
The global Complement Targeted Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Complement Targeted Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Complement Targeted Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Complement Targeted Therapeutics in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Complement Targeted Therapeutics include Creative Biolabs, Novartis AG, Alexion Pharmaceuticals, Merck, Pfizer, Allergan and AbbVie, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Complement Targeted Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Complement Targeted Therapeutics.
Report Scope
The Complement Targeted Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Complement Targeted Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Complement Targeted Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Creative Biolabs
Novartis AG
Alexion Pharmaceuticals
Merck
Pfizer
Allergan
AbbVie
Segment by Type
Paroxysmal Nocturnal Haemoglobinuria
Atypical Haemolytic Uraemic Syndrome (AHUS)
Segment by Application
Hospital Pharmacies
Retail Pharamacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Complement Targeted Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The complement system is a part of the immune system that enhances, or complements, the ability of antibodies to clear small organisms or damaged cells from an organism, promote inflammation and attack the pathogen’s cell membrane. While the complement system is essential to maintaining health, it can also become over-activated, contributing to the development of numerous devastating diseases.
The global Complement Targeted Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Complement Targeted Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Complement Targeted Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Complement Targeted Therapeutics in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Complement Targeted Therapeutics include Creative Biolabs, Novartis AG, Alexion Pharmaceuticals, Merck, Pfizer, Allergan and AbbVie, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Complement Targeted Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Complement Targeted Therapeutics.
Report Scope
The Complement Targeted Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Complement Targeted Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Complement Targeted Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Creative Biolabs
Novartis AG
Alexion Pharmaceuticals
Merck
Pfizer
Allergan
AbbVie
Segment by Type
Paroxysmal Nocturnal Haemoglobinuria
Atypical Haemolytic Uraemic Syndrome (AHUS)
Segment by Application
Hospital Pharmacies
Retail Pharamacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Complement Targeted Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Complement Targeted Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Paroxysmal Nocturnal Haemoglobinuria
1.2.3 Atypical Haemolytic Uraemic Syndrome (AHUS)
1.3 Market by Application
1.3.1 Global Complement Targeted Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharamacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Complement Targeted Therapeutics Market Perspective (2019-2030)
2.2 Complement Targeted Therapeutics Growth Trends by Region
2.2.1 Global Complement Targeted Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Complement Targeted Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Complement Targeted Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Complement Targeted Therapeutics Market Dynamics
2.3.1 Complement Targeted Therapeutics Industry Trends
2.3.2 Complement Targeted Therapeutics Market Drivers
2.3.3 Complement Targeted Therapeutics Market Challenges
2.3.4 Complement Targeted Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Complement Targeted Therapeutics Players by Revenue
3.1.1 Global Top Complement Targeted Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Complement Targeted Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Complement Targeted Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Complement Targeted Therapeutics Revenue
3.4 Global Complement Targeted Therapeutics Market Concentration Ratio
3.4.1 Global Complement Targeted Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Complement Targeted Therapeutics Revenue in 2023
3.5 Complement Targeted Therapeutics Key Players Head office and Area Served
3.6 Key Players Complement Targeted Therapeutics Product Solution and Service
3.7 Date of Enter into Complement Targeted Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Complement Targeted Therapeutics Breakdown Data by Type
4.1 Global Complement Targeted Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Complement Targeted Therapeutics Forecasted Market Size by Type (2025-2030)
5 Complement Targeted Therapeutics Breakdown Data by Application
5.1 Global Complement Targeted Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Complement Targeted Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Complement Targeted Therapeutics Market Size (2019-2030)
6.2 North America Complement Targeted Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Complement Targeted Therapeutics Market Size by Country (2019-2024)
6.4 North America Complement Targeted Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Complement Targeted Therapeutics Market Size (2019-2030)
7.2 Europe Complement Targeted Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Complement Targeted Therapeutics Market Size by Country (2019-2024)
7.4 Europe Complement Targeted Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Complement Targeted Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Complement Targeted Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Complement Targeted Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Complement Targeted Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Complement Targeted Therapeutics Market Size (2019-2030)
9.2 Latin America Complement Targeted Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Complement Targeted Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Complement Targeted Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Complement Targeted Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Complement Targeted Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Complement Targeted Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Complement Targeted Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Biolabs
11.1.1 Creative Biolabs Company Detail
11.1.2 Creative Biolabs Business Overview
11.1.3 Creative Biolabs Complement Targeted Therapeutics Introduction
11.1.4 Creative Biolabs Revenue in Complement Targeted Therapeutics Business (2019-2024)
11.1.5 Creative Biolabs Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Detail
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Complement Targeted Therapeutics Introduction
11.2.4 Novartis AG Revenue in Complement Targeted Therapeutics Business (2019-2024)
11.2.5 Novartis AG Recent Development
11.3 Alexion Pharmaceuticals
11.3.1 Alexion Pharmaceuticals Company Detail
11.3.2 Alexion Pharmaceuticals Business Overview
11.3.3 Alexion Pharmaceuticals Complement Targeted Therapeutics Introduction
11.3.4 Alexion Pharmaceuticals Revenue in Complement Targeted Therapeutics Business (2019-2024)
11.3.5 Alexion Pharmaceuticals Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Complement Targeted Therapeutics Introduction
11.4.4 Merck Revenue in Complement Targeted Therapeutics Business (2019-2024)
11.4.5 Merck Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Complement Targeted Therapeutics Introduction
11.5.4 Pfizer Revenue in Complement Targeted Therapeutics Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 Allergan
11.6.1 Allergan Company Detail
11.6.2 Allergan Business Overview
11.6.3 Allergan Complement Targeted Therapeutics Introduction
11.6.4 Allergan Revenue in Complement Targeted Therapeutics Business (2019-2024)
11.6.5 Allergan Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Detail
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Complement Targeted Therapeutics Introduction
11.7.4 AbbVie Revenue in Complement Targeted Therapeutics Business (2019-2024)
11.7.5 AbbVie Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
